Company: FCRX
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0000950170-25-023153
Chunk: 594

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 594
---
 
    7,264

    7,169

    1.0

    7,192

    Alcanza Clinical Research (4)(5)
    Senior Secured First Lien Revolver

    12/2027
     
    —

    (2
    )

    (0.0
    )

    (1
    )

    BioAgilytix
    Senior Secured First Lien Term Loan
    S + 625  (75 Floor) (including 275 PIK)
    11.70%
    12/2028
     
    13,400

    13,180

    1.6

    11,973

    BioAgilytix
    Senior Secured First Lien Delayed Draw Term Loan
    S + 625  (75 Floor) (including 275 PIK)
    11.70%
    12/2028
     
    696

    686

    0.1

    622

    LSCS Holdings, Inc. (Eversana) (12)
    Senior Secured Second Lien Term Loan
    S + 800  (50 Floor)
    13.47%
    12/2029
     
    14,700

    14,414

    1.7

    13,082

    Teal Acquisition Co., Inc
    Unitranche First Lien Term Loan
    S + 625  (100 Floor)
    11.74%
    09/2026
     
    2,174

    2,141

    0.3

    2,173

    Teal Acquisition Co., Inc (4)(5)
    Unitranche First Lien Revolver

    09/2026
     
    —

    (18
    )

    —

    —

126

    CRESCENT CAPITAL BDC, INC.Consolidated Schedule of InvestmentsDecember 31, 2023(in thousands, except share and per share data)

    Country/Security/Industry/Company
    Investment Type
    InterestTerm *
    InterestRate
    Maturity/DissolutionDate
    PrincipalAmount, Par Value or Shares **

    Cost

    Percentageof NetAssets ***

    FairValue

    Teal Acquisition Co., Inc
    Unitranche First Lien Term Loan
    S